Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
JAMA
    September 2024
  1. CLIFF ERS, Tessema FA
    The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease.
    JAMA. 2024;332:703-704.
    >> Share

    August 2024
  2. CANTOR AG, Holmes R, Bougatsos C, Atchison C, et al
    Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2024 Aug 20. doi: 10.1001/jama.2024.13546.
    >> Share

  3. JIN J
    Screening for Iron Deficiency and Iron Deficiency Anemia During Pregnancy.
    JAMA. 2024 Aug 20. doi: 10.1001/jama.2024.14791.
    >> Share

  4. DURYEA EL, Spong CY
    Anemic Data for Preventive Screening and Supplementation to Address Iron Deficiency Anemia in Pregnancy.
    JAMA. 2024 Aug 20. doi: 10.1001/jama.2024.13545.
    >> Share

  5. NICHOLSON WK, Silverstein M, Wong JB, Chelmow D, et al
    Screening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2024 Aug 20. doi: 10.1001/jama.2024.15196.
    >> Share

    January 2024
  6. HARRIS E
    Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy.
    JAMA. 2024;331:280.
    >> Share

    October 2023
  7. SIEGAL DM, Belley-Cote EP, Lee SF, Hill S, et al
    Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.
    JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20820.
    >> Share

  8. RAASVELD SJ, de Bruin S, Reuland MC, van den Oord C, et al
    Red Blood Cell Transfusion in the Intensive Care Unit.
    JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20737.
    >> Share

  9. HARRIS E
    Stem Cell Gene Editing Improved Sickle Cell Disease Outcomes.
    JAMA. 2023;330:1218.
    >> Share

    June 2023
  10. HARRIS E
    Daily Dose of Aspirin Linked With Anemia in Older People.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11954.
    >> Share

  11. WEYAND AC, Chaitoff A, Freed GL, Sholzberg M, et al
    Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020.
    JAMA. 2023;329:2191-2193.
    >> Share

    February 2023
  12. HARRIS E
    FDA Approves First Oral Treatment for Kidney Disease-Induced Anemia.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1556.
    >> Share

  13. LARKIN HD
    Sickle Cell Disease Gene Therapy Trial Paused.
    JAMA. 2023;329:364.
    >> Share

    November 2022
  14. VLACHADIS N, Vrachnis N
    A Review of Sickle Cell Disease.
    JAMA. 2022;328:1979.
    >> Share

  15. KAVANAGH PL, Fasipe T, Wun T
    A Review of Sickle Cell Disease-Reply.
    JAMA. 2022;328:1979-1980.
    >> Share

  16. LARKIN HD
    Gene Therapy for Sickle Cell Disease, beta-Thalassemia Enters Regulatory Reviews.
    JAMA. 2022;328:1798.
    >> Share

    October 2022
  17. KUEHN BM
    Children With Sickle Cell Anemia Not Receiving Recommended Care.
    JAMA. 2022;328:1583-1584.
    >> Share

    September 2022
  18. RUBIN R
    New Gene Therapy for beta-Thalassemia.
    JAMA. 2022;328:1030.
    >> Share

    August 2022
  19. SLOMSKI A
    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.
    >> Share

    July 2022
  20. KAVANAGH PL, Fasipe TA, Wun T
    Sickle Cell Disease: A Review.
    JAMA. 2022;328:57-68.
    >> Share

    June 2022
  21. OSHIMA T, Kinjo K, Kinjo M
    Chronic Abdominal Pain and Anemia in a 59-Year-Old Man.
    JAMA. 2022 Jun 24. pii: 2793812. doi: 10.1001/jama.2022.9194.
    >> Share

    February 2022
  22. SLOMSKI A
    Oral Daprodustat Treats Anemia in Chronic Kidney Disease.
    JAMA. 2022;327:710.
    >> Share

    October 2021
  23. ABOU BAKER NM, Davis AM
    Gastrointestinal Evaluation of Iron Deficiency Anemia.
    JAMA. 2021;326:1624-1625.
    >> Share

    September 2021
  24. KENTER MJH, Cohen AF
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:974-975.
    >> Share

  25. GURKAN UA
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
    JAMA. 2021;326:975.
    >> Share

  26. CASELLA JF, Kronsberg SS, Gorney RT
    Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.
    JAMA. 2021;326:975-976.
    >> Share

    July 2021
  27. ZHANG H, Kilaru AS, Meisel ZF, Bao Y, et al
    Prescription Drug Monitoring Program Mandates and Opioids Dispensed Following Emergency Department Encounters for Patients With Sickle Cell Disease or Cancer With Bone Metastasis.
    JAMA. 2021;326:274-276.
    >> Share

    June 2021
  28. SATO T, Terada R, Ikeda T
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia.
    JAMA. 2021;325:2505-2506.
    >> Share

  29. DUCROCQ G, Simon T, Steg PG
    Effect of Restrictive or Liberal Blood Transfusion on Major Cardiovascular Events in Patients With Acute Myocardial Infarction and Anemia-Reply.
    JAMA. 2021;325:2506-2507.
    >> Share

    May 2021

  30. Foreign Letters: London.
    JAMA. 2021;325:1907.
    >> Share

    April 2021
  31. ZYLKE J
    Poloxamer 188 for Sickle Cell Disease.
    JAMA. 2021;325:1524.
    >> Share

  32. CASELLA JF, Barton BA, Kanter J, Black LV, et al
    Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    JAMA. 2021;325:1513-1523.
    >> Share

  33. EHRENREICH H, Neubauer AP, Miskowiak K
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years.
    JAMA. 2021;325:1470-1471.
    >> Share

  34. NATALUCCI G, Bucher HU, Fauchere JC
    Effect of Early Recombinant Human Erythropoietin on Neurodevelopmental Outcomes at Age 5 Years-Reply.
    JAMA. 2021;325:1471-1472.
    >> Share

    February 2021
  35. DUCROCQ G, Gonzalez-Juanatey JR, Puymirat E, Lemesle G, et al
    Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial.
    JAMA. 2021;325:552-560.
    >> Share

    January 2021
  36. ABBASI J
    Promising Strategies for Sickle Cell Disease and beta-Thalassemia.
    JAMA. 2021;325:121.
    >> Share

    December 2020
  37. NATALUCCI G, Latal B, Koller B, Ruegger C, et al
    Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.
    JAMA. 2020;324:2324-2327.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016